Attached files
| file | filename |
|---|---|
| EX-99.3 - EX-99.3 - Celldex Therapeutics, Inc. | a17-3137_1ex99d3.htm |
| EX-99.2 - EX-99.2 - Celldex Therapeutics, Inc. | a17-3137_1ex99d2.htm |
| EX-99.1 - EX-99.1 - Celldex Therapeutics, Inc. | a17-3137_1ex99d1.htm |
| 8-K/A - 8-K/A - Celldex Therapeutics, Inc. | a17-3137_18ka.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-8 (No. 333-117602, 333-151728, 333-189336 and 333-205694) and Registration Statement on Forms S-3 (No. 333-192640, 333-214882 and 333-215747) of Celldex Therapeutics, Inc. of our report dated April 27, 2016 relating to the financial statements of Kolltan Pharmaceuticals, Inc., which appears in this Current Report on Form 8-K/A of Celldex Therapeutics, Inc.
|
/s/PricewaterhouseCoopers LLP |
|
Boston, Massachusetts |
|
February 7, 2017 |